Global Incidence and Mortality of Gastric Cancer, 1980-2018.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 07 2021
Historique:
entrez: 26 7 2021
pubmed: 27 7 2021
medline: 4 1 2022
Statut: epublish

Résumé

Gastric cancer is one of the most common cancers, with a high mortality-to-incidence ratio. It is uncertain whether developed nations may encounter an increasing burden of gastric cancer in young adults, as occurs for other cancers. To evaluate the incidence and mortality of gastric cancer and compare the global incidence trends between younger (<40 years) and older (≥40 years) populations. This population-based cohort study analyzed data from global and national cancer registries, including data from 1980 to 2018, with at least 15 calendar years of incidence and mortality data. Data on age-standardized incidence and mortality rates of gastric cancer among 48 countries were retrieved from the Surveillance, Epidemiology, and End Results Program, the National Cancer Institute, the Nordic Cancer Registries, and the World Health Organization Mortality Database. The 10-year incidence trend of gastric cancer was assessed by age and sex. The 2018 GLOBOCAN database was used for reporting the global incidence and mortality of gastric cancer, the most recent data available at the time of analysis. Analyses were performed between January 10, 2020, and March 20, 2020. The average annual percent change (AAPC) of the incidence and mortality trends as evaluated by joinpoint regression analysis. A total of 1 033 701 new cases of gastric cancer and 782 685 related deaths were reported in 2018. Overall, the incidence of gastric cancer decreased in 29 countries, and mortality decreased in 41 countries. The age-standardized incidence of gastric cancer decreased from a range of 2.6 to 59.1 in 1980 to a range of 2.5 to 56.8 in 2018 per 100 000 persons. The overall age-standardized mortality rate changed from a range of 1.3 to 25.8 in 1980 to a range of 1.5 to 18.5 in 2018 per 100 000 persons, but increasing mortality was observed in Thailand (female: AAPC, 5.30; 95% CI, 4.38-6.23; P < .001; male: AAPC, 3.92; 95% CI, 2.14-5.74; P < .001). The incidence of gastric cancer decreased in most regions among individuals 40 years or older and increased in populations younger than 40 years in several countries, including Sweden (male: AAPC, 13.92; 95% CI, 7.16-21.11; P = .001), Ecuador (female: AAPC, 6.05; 95% CI, 1.40-10.92; P = .02), and the UK (male: AAPC, 4.27; 95% CI, 0.15-8.55; P = .04; female: AAPC, 3.60; 95% CI, 3.59-3.61; P < .001). In this population-based cohort study, an increasing incidence of gastric cancer was observed in younger individuals in some countries, highlighting the need for more preventive strategies in younger populations. Future research should explore the reasons for these epidemiologic trends.

Identifiants

pubmed: 34309666
pii: 2782336
doi: 10.1001/jamanetworkopen.2021.18457
pmc: PMC8314143
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2118457

Subventions

Organisme : NCI NIH HHS
ID : K08 CA230162
Pays : United States

Références

PLoS One. 2015 May 29;10(5):e0128501
pubmed: 26023935
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):42-54
pubmed: 31648970
Int J Cancer. 2017 Oct 1;141(7):1333-1344
pubmed: 28614909
Gastric Cancer. 2007;10(2):75-83
pubmed: 17577615
Am J Gastroenterol. 1999 Aug;94(8):2094-9
pubmed: 10445533
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Eur Urol. 2016 Nov;70(5):862-874
pubmed: 27289567
Clin Gastroenterol Hepatol. 2021 May;19(5):955-966.e61
pubmed: 32088300
Cancer Causes Control. 2008 Sep;19(7):689-701
pubmed: 18293090
Singapore Med J. 2014 Dec;55(12):621-8
pubmed: 25630323
Nutrients. 2014 Sep 18;6(9):3734-46
pubmed: 25237829
Microbes Infect. 2003 Jul;5(8):693-703
pubmed: 12814770
JAMA. 2016 Feb 16;315(7):703-5
pubmed: 26881375
Cancer Sci. 2005 Jan;96(1):1-6
pubmed: 15649247
Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Jun;24(6):443-6
pubmed: 12848905
Ann Oncol. 2014 Jun;25(6):1228-33
pubmed: 24618149
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Acta Oncol. 2010 Jun;49(5):725-36
pubmed: 20491528
J Oncol. 2017;2017:3456264
pubmed: 28421114
Gastroenterol Res Pract. 2020 Mar 2;2020:9512707
pubmed: 32190044
Eur J Epidemiol. 2020 Jul;35(7):673-683
pubmed: 32448986
IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
pubmed: 15285078
Gastric Cancer. 2017 Mar;20(Suppl 1):3-7
pubmed: 27757699
Cancer Manag Res. 2018 Feb 07;10:239-248
pubmed: 29445300
World J Gastrointest Oncol. 2010 Feb 15;2(2):59-64
pubmed: 21160922
Eur J Cancer. 2009 Nov;45(16):2867-73
pubmed: 19427197
Gan. 1957 Jun;48(2):219-25
pubmed: 13474150
Ann Oncol. 2012 Jan;23(1):28-36
pubmed: 21536659
Ann Clin Microbiol Antimicrob. 2005 Oct 31;4:17
pubmed: 16262889
J Cancer Res Clin Oncol. 1991;117(2):133-43
pubmed: 2036128
World J Gastroenterol. 2014 Oct 14;20(38):13734-40
pubmed: 25320511
Metabolism. 2019 Mar;92:121-135
pubmed: 30445141
Prz Gastroenterol. 2019;14(1):26-38
pubmed: 30944675
Obesity (Silver Spring). 2018 Apr;26(4):641-650
pubmed: 29570247
Front Biosci (Landmark Ed). 2009 Jan 01;14:1490-504
pubmed: 19273142
J Gastroenterol Hepatol. 2010 Mar;25(3):479-86
pubmed: 20370726
Acta Oncol. 2018 Sep;57(9):1173-1178
pubmed: 29600886
Bull World Health Organ. 2005 Mar;83(3):171-7
pubmed: 15798840
Stat Med. 2009 Dec 20;28(29):3670-82
pubmed: 19856324
Epidemiol Rev. 1986;8:1-27
pubmed: 3533579
Gastroenterology. 2001 Dec;121(6):1286-93
pubmed: 11729107
IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
pubmed: 7715068
Int J Cancer. 2015 Jan 15;136(2):487-90
pubmed: 24889903
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Ann Intern Med. 2012 Jun 5;156(11):757-66, W-260
pubmed: 22665813
Acta Biomed. 2018 Dec 17;89(8-S):82-87
pubmed: 30561423
J Clin Oncol. 2013 Jun 10;31(17):2136-45
pubmed: 23650427
Cancer. 2003 Sep 1;98(5):940-8
pubmed: 12942560
N Engl J Med. 1996 Jul 25;335(4):242-9
pubmed: 8657240
Br J Cancer. 2015 May 26;112(11):1805-15
pubmed: 25928706
Helicobacter. 2007 Aug;12(4):333-40
pubmed: 17669107

Auteurs

Martin C S Wong (MCS)

The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong.
Department of Global Health, School of Public Health, The Peking University, Beijing, China.
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Junjie Huang (J)

The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong.

Paul S F Chan (PSF)

The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong.

Peter Choi (P)

The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong.

Xiang Qian Lao (XQ)

The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong.

Shannon Melissa Chan (SM)

Department of Surgery, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong.

Anthony Teoh (A)

Department of Surgery, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong.

Peter Liang (P)

Division of Gastroenterology, Department of Medicine, NYU Langone Health, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH